Ammonia intoxication in rats: protection by N-carbamoyl-L-glutamate plus L-arginine
- PMID: 4509311
- PMCID: PMC389814
- DOI: 10.1073/pnas.69.12.3530
Ammonia intoxication in rats: protection by N-carbamoyl-L-glutamate plus L-arginine
Abstract
Rats given a lethal dose (LD(99.9)) of ammonium acetate (10.8 mmol/kg of body weight) were protected to the extent of 85 and 76% when previously injected with N-carbamoyl glutamate or L-arginine, respectively, at a level of 4 mmol/kg of body weight. At a dose of 1 mmol/kg of body weight, L-arginine protected 24%, while N-carbamoyl-L-glutamate protected 61% of the animals. When a combination of N-carbamoyl-L-glutamate plus L-arginine (1 mmol each per kg of body weight) was injected, 100% of the rats were protected. The efficacy of N-carbamoyl-L-glutamate is related to its role as an activator of mitochondrial carbamoyl phosphate synthetase (EC 2.7.2.5) and its resistance to hydrolysis by tissue acylaminoacid acylase. N-Acetyl-L-glutamate, the naturally occurring and most effective activator of mitochondrial carbamoyl phosphate synthetase, was relatively ineffective in protection against lethal dose of ammonium acetate, because of its ready hydrolysis by acylaminoacid acylase. The findings reported provide a rational basis for the use of N-carbamoyl-L-glutamate plus L-arginine in the prevention and treatment of hyperammonemia in clinical conditions of liver disease and parental infusion of amino acids, and in feeding of urea supplements to ruminants.
Similar articles
-
Mixture of N-carbamoyl-L-glutamate plus L-arginine can protect rats with liver cirrhosis from acute ammonia intoxication.J Hepatol. 2001 Dec;35(6):719-25. doi: 10.1016/s0168-8278(01)00199-4. J Hepatol. 2001. PMID: 11738098
-
N-carbamoyl-L-glutamate plus L-arginine can protect ammonia intoxication in rats with reduced functional liver mass.Biochem Biophys Res Commun. 1998 Jul 20;248(2):391-4. doi: 10.1006/bbrc.1998.8984. Biochem Biophys Res Commun. 1998. PMID: 9675147
-
DEVELOPMENT OF UREA-CYCLE ENZYMES IN THE JUVENILE RAT: EFFECT OF LONG-TERM ADMINISTRATION OF L-MONOSODIUM GLUTAMATE AND AMMONIUM ACETATE.Am J Dig Dis. 1965 Sep;10:814-25. doi: 10.1007/BF02233773. Am J Dig Dis. 1965. PMID: 14331010 No abstract available.
-
Enzymes of arginine and urea synthesis.Adv Enzymol Relat Areas Mol Biol. 1973;39:1-90. doi: 10.1002/9780470122846.ch1. Adv Enzymol Relat Areas Mol Biol. 1973. PMID: 4355767 Review. No abstract available.
-
Hereditary metabolic disorders of the urea cycle.Adv Clin Chem. 1971;14:65-143. doi: 10.1016/s0065-2423(08)60145-6. Adv Clin Chem. 1971. PMID: 4944564 Review. No abstract available.
Cited by
-
Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders.Expert Rev Endocrinol Metab. 2016;11(6):467-473. doi: 10.1080/17446651.2016.1239526. Epub 2016 Sep 28. Expert Rev Endocrinol Metab. 2016. PMID: 30034506 Free PMC article.
-
New developments in the treatment of hyperammonemia: emerging use of carglumic acid.Int J Gen Med. 2011 Jan 7;4:21-8. doi: 10.2147/IJGM.S10490. Int J Gen Med. 2011. PMID: 21403788 Free PMC article.
-
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.Ther Clin Risk Manag. 2011;7:327-32. doi: 10.2147/TCRM.S12703. Epub 2011 Aug 2. Ther Clin Risk Manag. 2011. PMID: 21941437 Free PMC article.
-
A novel biochemically salvageable animal model of hyperammonemia devoid of N-acetylglutamate synthase.Mol Genet Metab. 2012 Jun;106(2):160-8. doi: 10.1016/j.ymgme.2012.03.004. Epub 2012 Mar 17. Mol Genet Metab. 2012. PMID: 22503289 Free PMC article.
-
N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.Appl Clin Genet. 2011 Aug 24;4:127-35. doi: 10.2147/TACG.S12702. Print 2011. Appl Clin Genet. 2011. PMID: 23776373 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials